Zobrazeno 1 - 10 of 405 pro vyhledávání: '"Raymund R Razonable"'
1
Akademický článek
Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records.
Autor: Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable
Publikováno v: PLoS ONE, Vol 19, Iss 7, p e0304822 (2024)
BackgroundTo describe outcomes of high-risk patients with coronavirus disease 2019 (COVID-19) treated with sotrovimab, other monoclonal antibodies (mAbs), or antivirals, and patients who did not receive early COVID-19 treatment. We also evaluate the
Externí odkaz: https://doaj.org/article/40b9c0a553614aab870c96814abcc136
Zobrazit plný text záznamu
2
Akademický článek
Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
Autor: Maria Lourdes Gonzalez Suarez, Kristin C Mara, Christina G Rivera, Supavit Chesdachai, Evan Draper, Raymund R Razonable
Publikováno v: PLoS ONE, Vol 19, Iss 6, p e0303896 (2024)
Background and aimRenal dysfunction is associated with poor outcomes in patients with coronavirus disease 2019 (COVID-19). In an effort to improve outcomes, intravenous remdesivir has been broadly used for the treatment of COVID-19 even in patients w
Externí odkaz: https://doaj.org/article/93f5ec8fe68a4e5d9066424c6b0dc5d7
Zobrazit plný text záznamu
3
Akademický článek
Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
Autor: Raymund R Razonable MD, Ravindra Ganesh MBBS, MD, Rachel K Bishop RN, Tracy L Culbertson MSN, RN, Molly Destro Borgen MA, Michelle C Hedin MSN, RN, Laura H Hopkins RN, Tammy A Jackson RN, Jennifer J Larsen MSN, RN, Jennifer A Matoush APRN, MS, Darcie E Moehnke MAN, RN, Shelly M Olson MSN, RN, Kellie M Peterson RN, Jordan Rosedahl BS, Lindsey M Philpot PhD, MPH
Publikováno v: Journal of Patient Experience, Vol 9 (2022)
Anti-spike monoclonal antibodies emerged as effective early treatment of high-risk individuals with mild-to-moderate COVID-19. Although their clinical and safety outcomes have been reported, patient perspectives of these experimental therapies have n
Externí odkaz: https://doaj.org/article/dcb231726295462da6abfc6513d572ec
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje